Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-27 11:01 am Purchase | 13G | Savara Inc SVRA | Frazier Life Sciences Public Fund L.P. | 8,660,379 5.000% | 8,660,379 (New Position) | View |
| 2024-11-20 10:44 am Purchase | 13G | MACROGENICS INC MGNX | Frazier Life Sciences Public Fund L.P. | 3,175,665 5.100% | 3,175,665 (New Position) | View |
| 2024-11-07 2:34 pm Purchase | 13D | KalVista Pharmaceuticals Inc. KALV | Frazier Life Sciences Public Fund L.P. | 4,887,867 10.000% | 1,200,000 (+32.54%) | View |
| 2024-11-06 10:30 am Purchase | 13G | Trevi Therapeutics Inc. TRVI | Frazier Life Sciences Public Fund L.P. | 7,381,090 10.200% | 717,500 (+10.77%) | View |
| 2024-11-05 11:44 am Purchase | 13G | Eledon Pharmaceuticals Inc. ELDN | Frazier Life Sciences Public Fund L.P. | 3,561,644 6.100% | 3,561,644 (New Position) | View |
| 2024-09-23 10:48 am Purchase | 13D | MBX BIOSCIENCES INC MBX | Frazier Life Sciences Public Fund L.P. | 5,985,347 18.800% | 5,985,347 (New Position) | View |
| 2024-08-22 4:05 pm Purchase | 13D | Phathom Pharmaceuticals Inc. PHAT | Frazier Life Sciences Public Fund L.P. | 12,788,710 18.000% | 2,618,922 (+25.75%) | View |
| 2024-07-15 1:17 pm Purchase | 13G | Elevation Oncology Inc. ELEV | Frazier Life Sciences Public Fund L.P. | 5,993,579 11.000% | 3,035,000 (+102.58%) | View |
| 2024-06-25 10:06 am Purchase | 13G | Disc Medicine Inc. IRON | Frazier Life Sciences Public Fund L.P. | 1,754,834 5.900% | 1,754,834 (New Position) | View |
| 2024-06-06 1:59 pm Purchase | 13D | Phathom Pharmaceuticals Inc. PHAT | Frazier Life Sciences Public Fund L.P. | 10,169,788 17.400% | 44,000 (+0.43%) | View |
| 2024-05-31 2:00 pm Purchase | 13D | HILLEVAX INC HLVX | Frazier Life Sciences Public Fund L.P. | 10,639,562 21.400% | 833,090 (+8.50%) | View |
| 2024-05-29 11:55 am Purchase | 13G | ERASCA INC ERAS | Frazier Life Sciences Public Fund L.P. | 16,216,216 5.900% | 16,216,216 (New Position) | View |
| 2024-05-06 12:59 pm Purchase | 13G | ANAPTYSBIO INC ANAB | Frazier Life Sciences Public Fund L.P. | 1,917,191 7.000% | 1,917,191 (New Position) | View |
| 2024-04-10 4:44 pm Purchase | 13G | AN2 Therapeutics Inc. ANTX | Frazier Life Sciences Public Fund L.P. | 1,488,889 5.000% | 1,488,889 (New Position) | View |
| 2024-04-09 4:26 pm Purchase | 13G | Elevation Oncology Inc. ELEV | Frazier Life Sciences Public Fund L.P. | 2,958,579 6.100% | 2,958,579 (New Position) | View |
| 2024-03-29 10:40 am Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | Frazier Life Sciences Public Fund L.P. | 2,631,713 5.400% | 2,631,713 (New Position) | View |
| 2024-02-22 1:22 pm Purchase | 13D | KalVista Pharmaceuticals Inc. KALV | Frazier Life Sciences Public Fund L.P. | 3,687,867 8.900% | 105,573 (+2.95%) | View |
| 2024-02-13 12:44 pm Sale | 13G | Gritstone bio Inc. GRTS | Frazier Life Sciences Public Fund L.P. | 1,092,185 1.100% | -4,131,470 (-79.09%) | View |
| 2024-02-13 12:36 pm Sale | 13G | Theseus Pharmaceuticals Inc. THRX | Frazier Life Sciences Public Fund L.P. | 0 0.000% | -2,248,194 (Position Closed) | View |
| 2024-02-09 11:41 am Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Frazier Life Sciences Public Fund L.P. | 10,416,666 11.000% | 10,416,666 (New Position) | View |